These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 11842368

  • 1. [Screening for aneuploidy by first trimester nuchal translucency measurement: results from a prospective trial including 1980 cases in a single center in Switzerland].
    Tercanli S, Holzgreve W, Batukan C, Gerber A, Ermis H, Miny P.
    Ultraschall Med; 2002 Feb; 23(1):22-6. PubMed ID: 11842368
    [Abstract] [Full Text] [Related]

  • 2. First-trimester screening for aneuploidy with fetal nuchal translucency in a United States population.
    Chasen ST, Sharma G, Kalish RB, Chervenak FA.
    Ultrasound Obstet Gynecol; 2003 Aug; 22(2):149-51. PubMed ID: 12905508
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Screening for trisomy 21 by fetal nuchal translucency and maternal age: a multicenter project in Germany, Austria and Switzerland.
    Gasiorek-Wiens A, Tercanli S, Kozlowski P, Kossakiewicz A, Minderer S, Meyberg H, Kamin G, Germer U, Bielicki M, Hackelöer BJ, Sarlay D, Kuhn P, Klapp J, Bahlmann F, Pruggmayer M, Schneider KT, Seefried W, Fritzer E, von Kaisenberg CS, German-Speaking Down Syndrome Screening Group.
    Ultrasound Obstet Gynecol; 2001 Dec; 18(6):645-8. PubMed ID: 11844207
    [Abstract] [Full Text] [Related]

  • 5. Clinical use of first-trimester aneuploidy screening in a United States population can replicate data from clinical trials.
    Perni SC, Predanic M, Kalish RB, Chervenak FA, Chasen ST.
    Am J Obstet Gynecol; 2006 Jan; 194(1):127-30. PubMed ID: 16389021
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. First-trimester screening for chromosomal abnormalities by fetal nuchal translucency in a Brazilian population.
    Brizot ML, Carvalho MH, Liao AW, Reis NS, Armbruster-Moraes E, Zugaib M.
    Ultrasound Obstet Gynecol; 2001 Dec; 18(6):652-5. PubMed ID: 11844209
    [Abstract] [Full Text] [Related]

  • 9. Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening.
    Tsai MS, Huang YY, Hwa KY, Cheng CC, Lee FK.
    J Formos Med Assoc; 2001 May; 100(5):319-25. PubMed ID: 11432311
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group.
    Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH.
    Lancet; 1998 Aug 01; 352(9125):343-6. PubMed ID: 9717920
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Screening for aneuploidies by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-13+6 gestational weeks.
    Karadzov-Orlić N, Egić A, Filimonović D, Marinković M, Damnjanović-Pazin B, Milovanović Z, Joksić I, Branković S, Lukić R, Mandić V, Cerović N, Mojović D, Plamenac S, Stanković M, Maglić D, Mikovć Z.
    Srp Arh Celok Lek; 2012 Aug 01; 140(9-10):606-11. PubMed ID: 23289277
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.